Novacyt Sa Stock Annual Yield
NVYTF Stock | USD 0.64 0.06 8.57% |
Novacyt SA fundamentals help investors to digest information that contributes to Novacyt SA's financial success or failures. It also enables traders to predict the movement of Novacyt Pink Sheet. The fundamental analysis module provides a way to measure Novacyt SA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Novacyt SA pink sheet.
Novacyt |
Novacyt SA Company Annual Yield Analysis
Novacyt SA's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
Competition |
In accordance with the recently published financial statements, Novacyt SA has an Annual Yield of 0.0%. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Medical Devices (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
All Next | Launch Module |
Novacyt Fundamentals
Return On Equity | -0.0198 | |||
Return On Asset | 0.0145 | |||
Profit Margin | (0.1) % | |||
Operating Margin | 0.07 % | |||
Current Valuation | (50.49 M) | |||
Shares Outstanding | 70.63 M | |||
Shares Owned By Insiders | 3.49 % | |||
Shares Owned By Institutions | 1.60 % | |||
Price To Earning | 0.51 X | |||
Price To Book | 0.40 X | |||
Price To Sales | 1.04 X | |||
Revenue | 95.78 M | |||
Gross Profit | 64.87 M | |||
EBITDA | (1.71 M) | |||
Net Income | (9.73 M) | |||
Cash And Equivalents | 99.65 M | |||
Cash Per Share | 1.41 X | |||
Total Debt | 1.67 M | |||
Debt To Equity | 0.01 % | |||
Current Ratio | 4.66 X | |||
Book Value Per Share | 1.88 X | |||
Cash Flow From Operations | 15.69 M | |||
Earnings Per Share | (0.17) X | |||
Number Of Employees | 210 | |||
Beta | -2.16 | |||
Market Capitalization | 83.34 M | |||
Total Asset | 183.7 M | |||
Z Score | 29.4 | |||
Net Asset | 183.7 M |
About Novacyt SA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Novacyt SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Novacyt SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Novacyt SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Novacyt Pink Sheet
Novacyt SA financial ratios help investors to determine whether Novacyt Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Novacyt with respect to the benefits of owning Novacyt SA security.